- Bladder cancer
- Kidney cancer
- Prostate cancer
Samuel U. Takvorian, MD, MS
About me
- Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
My education and training
- Medical School: Harvard Medical School
- Residency: Mass General Brigham Healthcare Center - Chestnut Hill
- Fellowship: University of Pennsylvania Health System
Spoken languages
Reviews
801 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Qualifications and experience
- Medical Oncology, 2019
- Internal Medicine, 2017
- Academy Health, National
- American Society of Clinical Oncology, National
- American Society of Clinical Oncology, Cancer Communications Committee, National
- American Society of Clinical Oncology, Clinical Practice & Innovation Committee, National
- American Society of Clinical Oncology, Coverage & Reimbursement Steering Group, National
- Penn Genitourinary and Urologic Cancer Program
Treatments and conditions
Research
Publications
Crawford TB, Tayeb M, Barrett E, Al-Saleem T, Kondam P, Hausler R, Symecko H, Orr C, Wolfe CS, Mann D, Spielman K, Wong G, Haas NB, Narayan V, Robinson K, Takvorian S, Wong YN, Sokolova AO, Montgomery RB, Menendez C, Kelley MJ, Aiello LB, Garraway IP, Domchek SM, Maxwell KN. Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate Cancer , J Natl Compr Canc Netw: 2026
Aleixo G, Ani J, Ferrell WJ, Malik S, Peters S, Adams, Loreg M, Eckert A, Grant D, Perloff T, Syed M, Parikh RB, Gabriel P, Hughes S, Dotan E, Sedhom R, Takvorian SU. Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70): Protocol for a hybrid implementation-effectiveness study in three community oncology practices in the United States , Journal of Geriatric Oncology, 17(4): 2026
Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Narayan V, Mei L, Takvorian S, Haas NB, Parikh RB, Mistry R, Mamtani R. OncoEducate: A Pilot Study of Generative AI to Enhance Patient-Clinician Communication in Genitourinary Cancer Care , Oncologist: 2026
Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Parikh RB, Narayan V, Mei L, Takvorian SU, Balzer Haas N, Mistry R, and Mamtani R. OncoEducate: A pilot study of generative AI to support patient education in GU cancer care. , 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA., 44(7): 2026,713
Mo G, Maier S, Doyle M, Sweeney S, Orellana J, Farago L, Lloyd A, Mawema H, Bajaj A, Mei L, Takvorian SU, Haas NB, Ky B, Leong D, Narayan V. Cardiovascular risk evaluation in men with prostate cancer study (CARE-PC): Pilot study to assess patient awareness and risk mitigation. , 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA. : 2026
Pepin A, Doucette A, Narayan VK, Maxwell KN, Takvorian SU, O'Brien SR, Mankoff DA, Mulugeta PG, Taunk NK. Differential Response to (177)Lu-PSMA-617 in Patients with Tumor Suppressor Gene-Mutated Metastatic Castration-Resistant Prostate Cancer , J Nucl Med: 2026
Aleixo G, Ani J, Raghavendran K, Zuber C, Goldman N, Gabriel P, Singh A, Boisseau L, Takvorian S, Dougherty D, Dotan E, Sedhom R. Embedding Geriatric Oncology in a Community Practice of an Academic Health System: Implementation, Outcomes, and End-of-Life Impact , JCO Oncol Pract: 2026
Wainwright JV, Song W, Toneff H, Kalman J, Takvorian S, Rendle K. Effects of Integrating a Chatbot into Lung Cancer Care on Patient Medication Self Efficacy , American Society of Preventative Oncology: 2025
Abigail Pepin, Abigail Doucette, Neha Vapiwala, Vivek Narayan, Samuel Takvorian, Sophia O’Brien, David Mankoff, Philipose Mulugeta, Neil K. Taunk Safety of the Combination of External Beam Radiotherapy with 177Lu-PSMA-617 in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC) , The Journal of Nuclear Medicine: 2025
Crawford TB, Tayeb M, Barrett E, Al-Saleem T, Kondam P, Hausler R, Symecko H, Orr C, Wolfe C, Mann D, Spielman K, Wong G, Haas N, Narayan V, Robinson K, Takvorian S, Wong YN, Sokolova A, Montgomery RB, Menendez C, Kelley MJ, Aiello LB, Garraway IP, Domchek SM, Maxwell KN. Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patients , medRxiv: 2025